相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。EDC3 phosphorylation regulates growth and invasion through controlling P-body formation and dynamics
Jeremiah J. Bearss et al.
EMBO REPORTS (2021)
Direct reductive amination of ketones with amines by reductive aminases
Bo-Bo Li et al.
GREEN SYNTHESIS AND CATALYSIS (2021)
Structure-Based Design and Identification of FT-2102 (Olutasidenib), a Potent Mutant-Selective IDH1 Inhibitor
Justin A. Caravella et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Enantioselective oxygenation of exocyclic methylene groups by a manganese porphyrin catalyst with a chiral recognition site
Finn Burg et al.
CHEMICAL SCIENCE (2020)
Discovery and Optimization of Quinolinone Derivatives as Potent, Selective, and Orally Bioavailable Mutant Isocitrate Dehydrogenase 1 (mIDH1) Inhibitors
Jian Lin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Phosphorylation of DEPDC5, a component of the GATOR1 complex, releases inhibition of mTORC1 and promotes tumor growth
Sathish K. R. Padi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Reductive Amination in the Synthesis of Pharmaceuticals
Oleg Afanasyev et al.
CHEMICAL REVIEWS (2019)
mTOR as a central hub of nutrient signalling and cell growth
Joungmok Kim et al.
NATURE CELL BIOLOGY (2019)
PIM2 interacts with tristetraprolin and promotes breast can cer tumorigenesis
Chune Ren et al.
MOLECULAR ONCOLOGY (2018)
Control of mRNA decapping by autoinhibition
David R. Paquette et al.
NUCLEIC ACIDS RESEARCH (2018)
Mechanisms Behind Resistance to P13K Inhibitor Treatment Induced by the PIM Kinase
Jin H. Son et al.
MOLECULAR CANCER THERAPEUTICS (2018)
PIM Kinase Inhibitors Kill Hypoxic Tumor Cells by Reducing Nrf2 Signaling and Increasing Reactive Oxygen Species
Noel A. Warfel et al.
MOLECULAR CANCER THERAPEUTICS (2016)
PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression
Dai Horiuchi et al.
NATURE MEDICINE (2016)
PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer
Fara Braso-Maristany et al.
NATURE MEDICINE (2016)
Systematic Functional Characterization of Resistance to PI3K Inhibition in Breast Cancer
Xiuning Le et al.
CANCER DISCOVERY (2016)
Insulin receptor substrate 1 is a substrate of the Pim protein kinases
Jin H. Song et al.
ONCOTARGET (2016)
Mutations in DCPS and EDC3 in autosomal recessive intellectual disability indicate a crucial role for mRNA decapping in neurodevelopment
Iltaf Ahmed et al.
HUMAN MOLECULAR GENETICS (2015)
PIM kinase (and Akt) biology and signaling in tumors
Noel A. Warfel et al.
PHARMACOLOGY & THERAPEUTICS (2015)
The direct Myc target Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas
Linus Plym Forshell et al.
Oncotarget (2015)
The PIM family of oncoproteins: small kinases with huge implications in myeloid leukemogenesis and as therapeutic targets
Kumar Saurabh et al.
ONCOTARGET (2014)
Targeting PI3K/Akt/mTOR signaling in cancer
Camillo Porta et al.
FRONTIERS IN ONCOLOGY (2014)
The Pim protein kinases regulate energy metabolism and cell growth
Zanna Beharry et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphoma
Ying-Wei Lin et al.
BLOOD (2010)
PIM1 protein kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells
Fengxue Zhang et al.
CANCER BIOLOGY & THERAPY (2009)
Crystal structure of human Edc3 and its functional implications
Sharon H. M. Ling et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Pim kinase-dependent inhibition of c-Myc degradation
Y. Zhang et al.
ONCOGENE (2008)
The proline-rich akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1
Noriko Oshiro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40
Emilie Vander Haar et al.
NATURE CELL BIOLOGY (2007)
P bodies: at the crossroads of post-transcriptional pathways
Ana Eulalio et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
The survival kinases Akt and Pim as potential pharmacological targets
R Amaravadi et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Pim family kinases enhance tumor growth of prostate cancer cells
WW Chen et al.
MOLECULAR CANCER RESEARCH (2005)
Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival
PS Hammerman et al.
BLOOD (2005)
Processing bodies require RNA for assembly and contain nontranslating mRNAs
D Teixeira et al.
RNA (2005)
Targeted mRNA degradation by deadenylation-independent decapping
G Badis et al.
MOLECULAR CELL (2004)
分享论文
